Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin
Clicks: 254
ID: 14093
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
64.2
/100
254 views
203 readers
Trending
AI Quality Assessment
Not analyzed
| Reference Key |
alexopoulos2019initialmetabolism
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Alexopoulos, A. |
| Journal | metabolism: clinical and experimental |
| Year | 2019 |
| DOI | 10.1016/j.metabol.2019.06.012 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.